• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

橙皮素通过抑制RANKL诱导的破骨细胞生成以及Jnk介导的Irf-3/c-Jun激活来预防骨吸收。

Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation.

作者信息

Zhang Qiang, Tang Xinqiao, Liu Zhong, Song Xiaoxia, Peng Dan, Zhu Wei, Ouyang Zhengxiao, Wang Wanchun

机构信息

Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.

Department of Orthopedics, Xiangtan Central Hospital, Xiangtan, China.

出版信息

Front Pharmacol. 2018 Sep 11;9:1028. doi: 10.3389/fphar.2018.01028. eCollection 2018.

DOI:10.3389/fphar.2018.01028
PMID:30254586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6142014/
Abstract

Bone homeostasis and resorption is regulated by the proper activation of osteoclasts, whose stimulation largely depends on the receptor activator of nuclear factor κB ligand (RANKL)-RANK signaling. Herein, for the first time, we showed that interferon regulatory factor (Irf)-3 was intimately involved in RANKL-induced osteoclast formation. In addition, hesperetin (Hes) derived from citrus fruit could inhibit RANKL-induced osteoclast differentiation and maturation among three types of osteoclast precursors with inhibited formation of F-actin rings and resorption pits on bone slices. More importantly, by using SP600125, a selective Jnk inhibitor, we showed that Hes was able to significantly attenuate the Jnk downstream expression of Irf-3 and c-Jun, thereby inactivating NF-κB/MAPK signaling and transcriptional factor NFATc-1, leading to suppression of osteoclast-specific genes, which resulted in impaired osteoclastogenesis and functionality. An ovariectomized (OVX) osteoporosis mouse model demonstrated that Hes could increase trabecular bone volume fractions (BV/TV), trabecular thickness, and trabecular number, whereas it decreased trabecular separation in OVX mice with well-preserved trabecular bone architecture and decreased levels of TRAP-positive osteoclasts. This is further evidenced by the diminished serum expression of bone resorption marker CTX and enhanced production of osteoblastic ALP . Taken together, these results suggested that Hes could inhibit Jnk-mediated Irf-3/c-Jun activation, thus attenuating RANKL-induced osteoclast formation and function both and .

摘要

骨稳态和骨吸收由破骨细胞的适当激活来调节,破骨细胞的刺激很大程度上取决于核因子κB受体激活剂配体(RANKL)-RANK信号通路。在此,我们首次表明干扰素调节因子(Irf)-3密切参与RANKL诱导的破骨细胞形成。此外,源自柑橘类水果的橙皮素(Hes)可抑制RANKL诱导的三种破骨细胞前体的破骨细胞分化和成熟,抑制骨切片上F-肌动蛋白环和吸收陷窝的形成。更重要的是,通过使用选择性Jnk抑制剂SP600125,我们发现Hes能够显著减弱Irf-3和c-Jun的Jnk下游表达,从而使NF-κB/MAPK信号通路和转录因子NFATc-1失活,导致破骨细胞特异性基因受到抑制,进而导致破骨细胞生成和功能受损。卵巢切除(OVX)骨质疏松小鼠模型表明,Hes可增加小梁骨体积分数(BV/TV)、小梁厚度和小梁数量,而降低OVX小鼠的小梁间距,同时保留良好的小梁骨结构,并降低抗酒石酸酸性磷酸酶(TRAP)阳性破骨细胞水平。骨吸收标志物CTX血清表达降低和成骨细胞碱性磷酸酶(ALP)产生增加进一步证明了这一点。综上所述,这些结果表明,Hes可抑制Jnk介导的Irf-3/c-Jun激活,从而在体内和体外减弱RANKL诱导的破骨细胞形成和功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/f9fd0d32a31f/fphar-09-01028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/b6f025692617/fphar-09-01028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/1b6f3359ce4f/fphar-09-01028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/9965f8c8ac17/fphar-09-01028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/7eb70335289b/fphar-09-01028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/b10de370405e/fphar-09-01028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/f9fd0d32a31f/fphar-09-01028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/b6f025692617/fphar-09-01028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/1b6f3359ce4f/fphar-09-01028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/9965f8c8ac17/fphar-09-01028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/7eb70335289b/fphar-09-01028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/b10de370405e/fphar-09-01028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873c/6142014/f9fd0d32a31f/fphar-09-01028-g006.jpg

相似文献

1
Hesperetin Prevents Bone Resorption by Inhibiting RANKL-Induced Osteoclastogenesis and Jnk Mediated Irf-3/c-Jun Activation.橙皮素通过抑制RANKL诱导的破骨细胞生成以及Jnk介导的Irf-3/c-Jun激活来预防骨吸收。
Front Pharmacol. 2018 Sep 11;9:1028. doi: 10.3389/fphar.2018.01028. eCollection 2018.
2
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
3
Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities.芫花素 B 通过抑制 NFATc1 和 ROS 活性抑制 RANKL 诱导的破骨细胞生成和去卵巢骨质疏松症。
Theranostics. 2019 Jul 3;9(16):4648-4662. doi: 10.7150/thno.35414. eCollection 2019.
4
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.马粟酸通过调节 RANKL 介导的 NF-κB 和 MAPK 信号通路抑制破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
5
Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.没食子儿茶素-3-没食子酸酯通过下调 c-Fos 表达和抑制核因子-κB 信号抑制破骨细胞生成。
Mol Pharmacol. 2010 Jan;77(1):17-25. doi: 10.1124/mol.109.057877. Epub 2009 Oct 14.
6
Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.甘草酸通过调节 NF-κB、ERK 和 JNK 信号通路抑制破骨细胞分化和绝经后骨质疏松症。
Eur J Pharmacol. 2019 Sep 15;859:172550. doi: 10.1016/j.ejphar.2019.172550. Epub 2019 Jul 16.
7
Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.持续缺氧通过调节 JNK 和 IκBα 的磷酸化来抑制破骨细胞分化和骨吸收。
Inflamm Res. 2019 Feb;68(2):157-166. doi: 10.1007/s00011-018-1209-9. Epub 2019 Jan 2.
8
Hydrogen gas protects against ovariectomy-induced osteoporosis by inhibiting NF-κB activation.氢气通过抑制 NF-κB 激活来预防去卵巢诱导的骨质疏松症。
Menopause. 2019 Jul;26(7):785-792. doi: 10.1097/GME.0000000000001310.
9
Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.甘草异甘草素抑制体外 RANKL 诱导的破骨细胞生成,并防止体内炎症性骨丢失。
Int J Biochem Cell Biol. 2012 Jul;44(7):1139-52. doi: 10.1016/j.biocel.2012.04.003. Epub 2012 Apr 12.
10
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.巴戟甲素通过抑制NF-κB和NFAT介导的RANKL信号通路来阻断破骨细胞分化。
Int J Mol Sci. 2017 Jan 19;18(1):203. doi: 10.3390/ijms18010203.

引用本文的文献

1
Nutraceuticals in osteoporosis prevention.用于预防骨质疏松症的营养保健品
Front Nutr. 2024 Oct 2;11:1445955. doi: 10.3389/fnut.2024.1445955. eCollection 2024.
2
Deletion of absent in melanoma-2 (AIM2) drives bone marrow adipogenesis and impairs bone microarchitecture.黑色素瘤缺失因子2(AIM2)的缺失会驱动骨髓脂肪生成并损害骨微结构。
Geroscience. 2025 Feb;47(1):795-807. doi: 10.1007/s11357-024-01354-2. Epub 2024 Sep 26.
3
Hesperetin Attenuates T-2 Toxin-Induced Chondrocyte Injury by Inhibiting the p38 MAPK Signaling Pathway.

本文引用的文献

1
Association of Vitamin D Receptor Gene Variation With Osteoporosis Risk in Belarusian and Lithuanian Postmenopausal Women.白俄罗斯和立陶宛绝经后女性维生素D受体基因变异与骨质疏松症风险的关联
Front Endocrinol (Lausanne). 2018 Jun 5;9:305. doi: 10.3389/fendo.2018.00305. eCollection 2018.
2
Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.Linc00462 通过 miR-665/TGFBR1-TGFBR2/SMAD2/3 通路促进胰腺癌侵袭性。
Cell Death Dis. 2018 Jun 13;9(6):706. doi: 10.1038/s41419-018-0724-5.
3
YAP promotes osteogenesis and suppresses adipogenic differentiation by regulating β-catenin signaling.
橙皮素通过抑制 p38 MAPK 信号通路减轻 T-2 毒素诱导的软骨细胞损伤。
Nutrients. 2024 Sep 14;16(18):3107. doi: 10.3390/nu16183107.
4
Zuogui Pill Ameliorates Glucocorticoid-Induced Osteoporosis through ZNF702P-Based ceRNA Network: Bioinformatics Analysis and Experimental Validation.左归丸通过基于ZNF702P的ceRNA网络改善糖皮质激素诱导的骨质疏松症:生物信息学分析与实验验证
Evid Based Complement Alternat Med. 2022 Aug 29;2022:8020182. doi: 10.1155/2022/8020182. eCollection 2022.
5
pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration.载柚皮苷的 pH 响应介孔硅纳米粒子用于靶向破骨细胞抑制和骨再生。
Int J Nanomedicine. 2024 Jun 24;19:6337-6358. doi: 10.2147/IJN.S456545. eCollection 2024.
6
Recent understanding of the mechanisms of the biological activities of hesperidin and hesperetin and their therapeutic effects on diseases.近期对橙皮苷和橙皮素生物活性机制及其对疾病治疗作用的认识。
Heliyon. 2024 Feb 28;10(5):e26862. doi: 10.1016/j.heliyon.2024.e26862. eCollection 2024 Mar 15.
7
Unveiling the potential of Butylphthalide: inhibiting osteoclastogenesis and preventing bone loss.揭示丁苯酞的潜力:抑制破骨细胞生成并预防骨质流失。
Front Pharmacol. 2024 Feb 23;15:1347241. doi: 10.3389/fphar.2024.1347241. eCollection 2024.
8
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.NFATc1在类风湿关节炎相关骨破坏中的最新进展:机制与潜在治疗靶点
Mol Med. 2024 Feb 3;30(1):20. doi: 10.1186/s10020-024-00788-w.
9
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB.黄瓜籽多肽通过 OPG/RANKL/RANK 和 NF-κB 调节 RANKL 诱导的破骨细胞生成。
In Vitro Cell Dev Biol Anim. 2024 Jan;60(1):54-66. doi: 10.1007/s11626-023-00834-7. Epub 2023 Dec 20.
10
Histone methyltransferase SETDB1 promotes osteogenic differentiation in osteoporosis by activating OTX2-mediated BMP-Smad and Wnt/β-catenin pathways.组蛋白甲基转移酶 SETDB1 通过激活 OTX2 介导的 BMP-Smad 和 Wnt/β-catenin 通路促进骨质疏松症中的成骨分化。
Hum Cell. 2023 Jul;36(4):1373-1388. doi: 10.1007/s13577-023-00902-w. Epub 2023 Apr 19.
YAP通过调节β-连环蛋白信号通路促进成骨作用并抑制脂肪生成分化。
Bone Res. 2018 Jun 1;6:18. doi: 10.1038/s41413-018-0018-7. eCollection 2018.
4
Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice.唑来膦酸可预防小鼠废用性骨质减少,并增强破骨细胞分化标志物的基因表达。
J Musculoskelet Neuronal Interact. 2018 Jun 1;18(2):165-175.
5
Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation.黄酮哌啶醇通过减弱RANKL诱导的破骨细胞形成来保护骨组织。
Front Pharmacol. 2018 May 3;9:174. doi: 10.3389/fphar.2018.00174. eCollection 2018.
6
Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.来那度胺通过 IL-1β/NF-κB/RANKL 信号通路调节破骨细胞前体细胞向成骨细胞分化及其相关的破骨细胞生成。
Biochem Biophys Res Commun. 2018 Jun 22;501(2):547-555. doi: 10.1016/j.bbrc.2018.05.035. Epub 2018 May 10.
7
Engineering 3D approaches to model the dynamic microenvironments of cancer bone metastasis.构建三维模型以模拟癌症骨转移动态微环境的工程方法。
Bone Res. 2018 Feb 26;6:3. doi: 10.1038/s41413-018-0008-9. eCollection 2018.
8
Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.金丝桃素作用于破骨细胞,并通过NFATc1信号通路预防乳腺癌诱导的骨转移。
Oncotarget. 2017 Dec 4;9(2):1868-1884. doi: 10.18632/oncotarget.22930. eCollection 2018 Jan 5.
9
The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption.前胡素C通过抑制破骨细胞形成和骨吸收对去卵巢小鼠骨质疏松性骨的有益作用。
Front Pharmacol. 2017 Sep 12;8:627. doi: 10.3389/fphar.2017.00627. eCollection 2017.
10
Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release.通过响应性白花丹素释放的治疗性上转换纳米粒子靶向破骨细胞来减轻早期乳腺癌骨转移。
ACS Nano. 2017 Jul 25;11(7):7259-7273. doi: 10.1021/acsnano.7b03197. Epub 2017 Jul 13.